FDA Inspection 1264589 — GC Hanford Manufacturing Company

GC Hanford Manufacturing Company — FEI 1310197

The FDA completed an inspection of GC Hanford Manufacturing Company on March 20, 2025 in Syracuse, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 20, 2025
Fiscal Year
2025
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Syracuse, NY (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
143021 CFR 211.42(c)(10)(i)Floors, walls, ceiling surfaces
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation